RedHill Biopharma Ltd. ( RDHL) - Stock Earnings
RDHL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | -2.6 million USD | 2.7 million USD |
| 2025Q1 | -2.1 million USD | 2.0 million USD |
| 2025Q2 | -2.1 million USD | 2.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RDHL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 23.9 million USD | 6.5 million USD |
| 2024 | -8.3 million USD | 8.0 million USD |
| 2025 | -429000 USD | 286000 USD |
| 2026 Est. | — | — |
RDHL
Price: $0.40
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Israel
Volume: 100.7 million
Ebitda: -13.8 millionMarket Capitalization: 1.6 million